BioCentury
ARTICLE | Company News

ALK-Abello, AllerQuest deal

July 18, 2011 7:00 AM UTC

AllerQuest granted ALK-Abello exclusive, worldwide rights to commercialize its Minor Determinant Mixture (MDM) penicillin allergy skin test. AllerQuest, which is developing MDM, is eligible up to $3.5...